Biotechnology Tag

NuVision Biotherapies is delighted to announce the appointment of its new chairman, Dr Mark Treherne.  Mark has a PhD in Pharmacology from Cambridge University along with over 25 years of industrial R&D experience in the discovery and development of novel treatments for diseases with unmet medical...